Search

everythinglearnresearchcommunity

for

Search:↓

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Quercetin may help with PCOS symptoms, but more research is needed.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Women with PCOS have lower amylin levels, which are not related to their body weight.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

19.7% of Afro-Caribbean women in Tobago have PCOS.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

The document is a detailed medical reference on skin and genetic disorders.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

A man's baldness improved possibly due to a medication that blocks male hormones.